Back
CI Gold+ Giants Covered Cll ETFUSDH Comm Vs. NovoCure Industry Stock Comparison
Buy
69
CGXF.U.TO
CI Gold+ Giants Covered Cll ETFUSDH Comm
Last Price:
8.51
Seasonality Move:
-10.6%
Buy
75
NVCR
NovoCure
Last Price:
33.40
Seasonality Move:
-5.24%
Buy
69
CI Gold+ Giants Covered Cll ETFUSDH Comm (CGXF.U.TO)
is a Buy
Is CI Gold+ Giants Covered Cll ETFUSDH Comm a Buy, Sell or Hold?
- The current CI Gold+ Giants Covered Cll ETFUSDH Comm [CGXF.U.TO] share price is $8.51. The Score for CGXF.U.TO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- CGXF.U.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
NovoCure (NVCR)
is a Buy
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $33.41. The Score for NVCR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- NVCR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CGXF.U.TO Stock Price Chart
What is CI Gold+ Giants Covered Cll ETFUSDH Comm's stock price today?
-
The CI Gold+ Giants Covered Cll ETFUSDH Comm share price today is $8.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CGXF.U.TO is experiencing slight buying pressure.
CGXF.U.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 54.06 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.14 - 8.48) | Buy |
Bollinger Bands (100): | (8.17 - 8.91) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.78 | Buy |
Relative Strength Index (14 RSI): | 75.34 | Buy |
Chaikin Money Flow: | 1118573 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.36 - 28.56) | Buy |
Bollinger Bands (100): | (14.7 - 22.78) | Buy |
CGXF.U.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.37 | Buy |
20-day SMA: | 8.33 | Buy |
50-day SMA: | 8.65 | Sell |
200-day SMA: | 8.08 | Buy |
8-day EMA: | 8.4 | Buy |
20-day EMA: | 8.41 | Buy |
50-day EMA: | 8.51 | Buy |
200-day EMA: | 8.23 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.6 | Buy |
20-day SMA: | 23.68 | Buy |
50-day SMA: | 19.33 | Buy |
200-day SMA: | 17.9 | Buy |
8-day EMA: | 29.53 | Buy |
20-day EMA: | 25.45 | Buy |
50-day EMA: | 21.38 | Buy |
200-day EMA: | 19.88 | Buy |
CI Gold+ Giants Covered Cll ETFUSDH Comm Earnings Growth & CGXF.U.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
CI Gold+ Giants Covered Cll ETFUSDH Comm Technical Analysis
Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |